Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus
31 August 2019 (14:37 - 14:55)
Organised by:
About the speaker
Brigham and Women's Hospital, Boston (United States of America)
3 More presentations in this session
Professor A. Norhammar (Stockholm, SE)
Mrs M. Elmegaard (Copenhagen, DK)
Access the full session
The Event
ESC Congress 2019
31 August 2019
14:37 CET
